Complications after second trimester surgical and medical abortion.
Grossman D, Blanchard K, Blumenthal P.
Reprod Health Matters. 2008 May;16(31 Suppl):173-82. doi: 10.1016/S0968-8080(08)31379-2.
Clinical application of low-dose misoprostol in the induced labor of 16 to 28 weeks pathological pregnancies (a STROBE-compliant article).
Yang Y, Wang Y, Du X, Duan J, Huang YM.
Medicine (Baltimore). 2019 Oct;98(40):e17396. doi: 10.1097/MD.0000000000017396.
[Intramuscular administration of Prostin for abortion in the second trimester].
Curić F, Vilendecić R.
Jugosl Ginekol Opstet. 1984 May-Aug;24(3-4):68-70.
[Artificial termination of pregnancy in late periods].
Nikonov AP.
Akush Ginekol (Mosk). 1987 Oct;(10):7-10.
Determinants of induction-to-expulsion time and adverse maternal outcomes of second trimester medical abortion in Amhara Region, Ethiopia: Prospective follow-up study.
Yitina EF, Mihrete GS, Bicha MM, Andualem BS, Addis NA, Abebe OM, Tolu LB, Lakew AM.
Afr J Reprod Health. 2025 Sep 29;29(9s):162-180. doi: 10.29063/ajrh2025/v29i9s.14.
Silent uterine rupture with the use of misoprostol for second trimester termination of pregnancy : a case report.
Cuellar Torriente M.
Obstet Gynecol Int. 2011;2011:584652. doi: 10.1155/2011/584652. Epub 2011 Apr 19.
Outcome of Mid Trimester Termination of Pregnancy in Previous Caesarian Section By Combined Mifepristone and Misoprostol.
Sultana N, Latif T, Nahar M, Hossain F, Islam MS, Salma U, Dhar S, Islam SS, Nath S.
Mymensingh Med J. 2026 Apr;35(2):349-355.
Termination of midtrimester pregnancies with extraovular 0.1% ethacridine lactate. Accurate method for estimation of blood loss. Role of spartein sulfate.
Laul RM, Mahale AR, Bhattacharya PR.
Asia Oceania J Obstet Gynaecol. 1984 Jun;10(2):185-9. doi: 10.1111/j.1447-0756.1984.tb00674.x.
Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveries.
Fawzy M, Abdel-Hady el-S.
Int J Gynaecol Obstet. 2010 Jul;110(1):50-2. doi: 10.1016/j.ijgo.2010.02.008. Epub 2010 Apr 2.
[Subchorionic hematoma as a risk factor of pregnancy and delivery in women with threatening abortion].
Biesiada L, Krekora M, Krasomski G.
Ginekol Pol. 2010 Dec;81(12):902-6.
